Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin’s Lymphoma (HL). Nevertheless, late toxicity still remains an issue. A modern approach in HL radiotherapy includes lower doses and smaller fields, together with the implementation of sophisticated and dedicated delivery techniques. Aim of the present review is to discuss the current role of radiotherapy and its potential future developments, with a focus on major clinical trials, technological advances and their repercussion in the clinical management of HL patients
Introduction: The historically feared radiation-induced secondary cancers and cardiac toxicities obs...
Introduction: The historically feared radiation-induced secondary cancers and cardiac toxicities obs...
Combined-modality treatment consisting of four to six cycles of chemotherapy followed by involved-fi...
Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin’s Lympho...
Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin's Lymphom...
AbstractThe role of radiotherapy is well established in combined modality programs for early stage H...
The role of radiotherapy is well established in combined modality programs for early stage Hodgkin's...
Hodgkin’s lymphoma (HL) belongs to the most radiosensitive and chemosensitive cancers. Combined moda...
Background The role of radiotherapy (RT) in the treatment of Hodgkin lymphoma (HL) has changed consi...
The treatment of Hodgkin's lymphoma (HL) is associated with significant toxicity. The objective of h...
A systematic review of radiation therapy trials in several tumour types was carried out by The Swedi...
In the past decades, Hodgkin lymphoma (HL) has turned from an incurable disease to one with the most...
Abstract: Since its beginning, more than 15.000 patients with Hodgkin’s lymphoma (HL) have been enro...
Copyright © 2015 Magdalena Witkowska et al. This is an open access article distributed under the Cre...
Early-stage Hodgkin lymphoma (HL) is a rare disease, and the location of lymphoma varies considerabl...
Introduction: The historically feared radiation-induced secondary cancers and cardiac toxicities obs...
Introduction: The historically feared radiation-induced secondary cancers and cardiac toxicities obs...
Combined-modality treatment consisting of four to six cycles of chemotherapy followed by involved-fi...
Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin’s Lympho...
Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin's Lymphom...
AbstractThe role of radiotherapy is well established in combined modality programs for early stage H...
The role of radiotherapy is well established in combined modality programs for early stage Hodgkin's...
Hodgkin’s lymphoma (HL) belongs to the most radiosensitive and chemosensitive cancers. Combined moda...
Background The role of radiotherapy (RT) in the treatment of Hodgkin lymphoma (HL) has changed consi...
The treatment of Hodgkin's lymphoma (HL) is associated with significant toxicity. The objective of h...
A systematic review of radiation therapy trials in several tumour types was carried out by The Swedi...
In the past decades, Hodgkin lymphoma (HL) has turned from an incurable disease to one with the most...
Abstract: Since its beginning, more than 15.000 patients with Hodgkin’s lymphoma (HL) have been enro...
Copyright © 2015 Magdalena Witkowska et al. This is an open access article distributed under the Cre...
Early-stage Hodgkin lymphoma (HL) is a rare disease, and the location of lymphoma varies considerabl...
Introduction: The historically feared radiation-induced secondary cancers and cardiac toxicities obs...
Introduction: The historically feared radiation-induced secondary cancers and cardiac toxicities obs...
Combined-modality treatment consisting of four to six cycles of chemotherapy followed by involved-fi...